Reference | Setting | Medicines | ADRs | Sampling period | Sample size | Outcome measures | Results (95% CI) | Type of ADRs |
---|---|---|---|---|---|---|---|---|
Case control studies | Â | Â | Â | Â | Â | Â | Â | Â |
Czeizel 1999 [15] | HU | Erythromycin | Teratology | 1980–1996 | 113 cases/38,151 controls | OR | 1.1; 0.5–2.3 | C |
Seeger 2006 [16] |  | Fluoroquinolones | Achilles tendon rupture | 1997–2001 | 947 cases/ 18,940 controls | OR | 1.2; 0.9–1.7 | B |
Cohort studies | Â | Â | Â | Â | Â | Â | Â | Â |
Chysky 1991[17] | DE | Ciprofloxacin | Not specified | 44 days | 634 patients | % ADRs | Different categories reported | A/B |
Derby 1993 [18] | AU | Flucloxacillin | Cholestatic hepatitis | 45 days | 132,087 patients | PRR/100,000 users | 7.6; 3.5–13.9 | B |
Jick 1994 [19] | AU | Flucloxacillin | Cholestatic hepatitis | 1991–1992 | 77,552 patients | PRR/ 100,000 users | 6.5; 2.7–15.1 | B |
Derby 1993b [20] | AU | Erythromycin | Cholestatic hepatitis | - | 366,064 patients | PRR/100,000 users | 3,6; 1.9–6.1 | B |
Heymann 2007 [21] | Israel | Penicillins | Pemphigus | 1997–2001 | 150,000 patients | OR | 2.03; 1.56–2.64 | B |
PEM | Â | Â | Â | Â | Â | Â | Â | Â |
Clark 2001 [22] | UK | Fluoroquinolones | Cardiovascular events | 1988–1991 | 36,410 patients | CRR (crude relative risk) | Atrial fibrillation: 1.0; 0.02 – 8.92 | B |
Inman1994 [23] | UK | Fluconazole | All | 1988–1989 | 15,015 patients | Frequencies | Different categories reported | A |
National ADR databases | Â | Â | Â | Â | Â | Â | Â | Â |
Polimeni 2006 [49] | Sicilian | Antibacterials | All | 1998–2002 | 1585 cases | ADRs | Different categories reported | A |
Sachs 2006 [24] | DE | Fluoroquinolones | Anaphylaxis | 1993–2004 | 204 cases | PRR > 2 | Moxifloxacin: 2.1; Ofloxacin: 2.3 Ciprofloxacin: 2.3 Levofloxacin: 2.0 | B |
Fleisch 2000 [25] | CH | Levofloxacin | Tendinopathy | 1986–1999 | 19 cases/460 non-cases | Reporting rate | Different categories reported | B |
Leone 2003 [26] | IT | Fluroquinolones | Not specified | 1999–2001 | 432 cases/ 10,011 non cases | Reporting rate | Different categories reported | A |
Pierfitte 2000 [27] | FR | Sparfloxacin | Phototoxicity | 1994–1996 | 371 cases | RtR/1000 patients | 0.4 | B |
Frothingham 2005 [28] | US | Gatifloxacin | Glucose homeostatis abnormalities | 1997–2003 | 453 cases/ 1427 non cases | Reporting rate/107 prescriptions | 477 | A |
Hedenmalm 1996 [29] | SE | Fluorquinolones | Sensory disturbances | 1965–1993 | 37 cases | ADRs | Different categories reported | A |
Case series | Â | Â | Â | Â | Â | Â | Â | Â |
Abouesh 2002 [30] | - | Fluorquinolones Macrolides | Mania | - | 102 cases | Case review | Case review | B |
Smith 2005 [31] | - | Doxycycline Minocycline | ADRs | 1966–2003 | 130 cases | Incidences | Doxycycline: 0–61% Minocycline: 11.7 – 83.3% | A |
Case reports | Â | Â | Â | Â | Â | Â | Â | Â |
Hällgren 2003 [32] | - | Ciprofloxacin | Steven-Johnson syndrome | 1988–2000 | 8 cases | IC pr. 100,000 patients | 0.045 | B |
Warner 2000 [33] | - | Clarithromycin | Acute Psychotic Stress | - | 1 case | Causality assessment | Possible | A |
ADRAC 1992 [34] | - | Flucloxacillin | Cholestatic hepatitis | - | 1 case | Case review | Case review | B |
Greco 1997 [35] | - | Clarithromycin | Glossitis, stomatitis, black tongue | - | 1 case | Case review | Case review | B |
Björnsson 1996 [36] | - | Doxycycline | Liver reactions | 1966–1995 | 23 cases | Causality assessment | Likely (n = 3) Possible (n = 8) | B |